No Data
No Data
Leerink Partners Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $122
Leerink Partners analyst Michael Cherny maintains $Cardinal Health(CAH.US)$ with a buy rating, and adjusts the target price from $120 to $122.According to TipRanks data, the analyst has a success
Cardinal Health: Navigating Inflation With Strategic Mitigation – Outperform Rating & $122 Target
Why the Market Dipped But Cardinal Health (CAH) Gained Today
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
How Is The Market Feeling About Cardinal Health?
Cardinal Health's (NYSE:CAH) short percent of float has fallen 17.69% since its last report. The company recently reported that it has 6.12 million shares sold short, which is 3.35% of all regular
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why